Literature DB >> 25563539

Overweight and distress have a joint association with long-term sickness absence among Dutch employees.

Yeshambel T Nigatu1, Corné A M Roelen, Sijmen A Reijneveld, Ute Bültmann.   

Abstract

OBJECTIVES: To examine separate and joint associations of overweight and distress with long-term sickness absence (LTSA).
METHODS: We included a total of 2724 Dutch employees participating in occupational health checks between 2008 and 2012. Overweight was defined as a body mass index of 25 kg/m2 or more; distress concerned a score of 10 or more on the Four-Dimensional Symptom Questionnaire. Long-term sickness absence was defined as sickness absence lasting more than 2 consecutive weeks. Synergy was estimated from logistic regression models using the synergy index.
RESULTS: The joint association of overweight and distress with LTSA was significant in women (odds ratio, 2.35; 95% confidence interval, 1.31 to 4.24), but not in men (odds ratio, 1.58; 95%confidence interval, 0.74 to 3.37). In women, we found a synergy index of 1.04 (95%confidence interval, 0.34 to 3.15).
CONCLUSIONS: The joint association of overweight and distress with LTSA was not synergistic. Addressing comorbid overweight and distress may help reduce the burden of LTSA in women.

Entities:  

Mesh:

Year:  2015        PMID: 25563539     DOI: 10.1097/JOM.0000000000000273

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Gender differences in the longitudinal association between obesity, and disability with workplace absenteeism in the Australian working population.

Authors:  Syed Afroz Keramat; Khorshed Alam; Jeff Gow; Stuart J H Biddle
Journal:  PLoS One       Date:  2020-05-27       Impact factor: 3.240

2.  Obesity and sickness absence: results from a longitudinal nationally representative sample from Germany.

Authors:  Katrin Christiane Reber; Hans-Helmut König; André Hajek
Journal:  BMJ Open       Date:  2018-06-06       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.